Hosted on MSN1mon
Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III
PFE markets Prevnar 20, which is approved for the prevention ... The FDA approved Capvaxive for 21 serotypes, which account for 84% of all IPDs in older adults in June 2024. Per Merck, Capvaxive ...
pharmaphorum3d
Vaxcyte's pneumococcal vaccine win points to Prevnar battle
It had a safety profile similar to Pfizer's market-leading Prevnar 20, which targets 20 common ... In June, MSD got FDA approval for a 21-valent vaccine, called Capvaxive, which is the first ...
Medscape1d
EMA Recommends Approval of Capvaxive Pneumococcal Vaccine
The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to ...
pharmaphorum1d
Merck's challenge to Pfizer's Prevnar grows
the latest member of its Prevnar family, which leads the market with sales of $6.3 billion last year. A second study, STRIDE-6, showed that V116 stimulated antibodies against all 21 S. pneumoniae ...
Monthly Prescribing Reference3y
Prevnar 20
After shipping, Prevnar 20 may arrive at temperatures between 2 ºC to 25 ºC (36 ºF to 77 ºF). Upon receipt, store refrigerated at 2 ºC to 8 ºC (36 ºF to 46 ºF). Do not freeze. Store ...
FiercePharma16d
In PAHO-backed access initiative, Argentina's Sinergium Biotech to locally produce Pfizer's Prevnar 20
Under the initiative, Buenos Aires-based Sinergium will produce Pfizer's Prevnar 20 in Argentina, with doses expected to be ready to roll out by 2026. In the meantime, countries across the ...